On the other hand, the MRN complex also exerts oncopromoting functions and confers survival advantages to tumour cells by facilitating resistance to oncogene‐induced RS, as demonstrated for MYCN‐driven neuroblastoma [31] and c‐MYC‐driven B‐cell lymphomas [32]. This evidence concerns the gene MYCN and neoplasm.